• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MIS18BP1通过使P53信号通路失活来促进膀胱癌细胞的增殖和生长。

MIS18BP1 promotes bladder cancer cell proliferation and growth via inactivating P53 signaling pathway.

作者信息

Cao WenJing, Tan XueYing, Li Xuze, Wang YuLin, Zhai YuQing, Zhang ZongLiang, Yuan JiangShui, Song WeiQing

机构信息

Department of Medicine, Qingdao University, Qingdao, China.

Department of Clinical Laboratory, Qingdao Municipal Hospital, Qingdao, China.

出版信息

Med Oncol. 2025 Apr 9;42(5):156. doi: 10.1007/s12032-025-02704-6.

DOI:10.1007/s12032-025-02704-6
PMID:40205244
Abstract

MIS18 bonding protein 1 (MIS18BP1) is a subunit of MIS18 complex, accumulated specifically at telophase-G1 centromere and regulated apoptosis, proliferation and migration in cancer cells. The mechanisms about how MIS18BP1 regulate Bladder Cancer (BCa) cell development have not been previously unknown. We analyzed MIS18BP1 differential expression in BCa by The Cancer Genome Atlas (TCGA), Gene-Expression Omnibus (GEO) and Universal Protein database. The expression of MIS18BP1 mRNA was tested using qRT-PCR. The expression of MIS18BP1 protein was examined by western blot and immunohistochemistry (IHC) staining. T24 cells were transfected with an LV -MIS18BP1 -RNAi vector to decrease the MIS18BP1 expression. We used a series of experiments to detect the survival, proliferation and migration of T24. The apoptosis was analyzed by Flow cytometry assays. The expression of P53, BAX and Cleaved Casepase-3 was detected by western blot. P53 apoptosis-related proteins, proliferation and migration of cells were analyzed before and after treatment with P53 inhibitors. The expression of MIS18BP1 was higher in BCa tissues compared with control group. Its expression was in relation to clinical stage, depth of invasion and lymph node metastasis. We found that genes closely related to MIS18BP1 are mainly associated with cell cycle, chromosome separation and DNA repair in biological processes. After transfection, we found the proliferative capacity of T24 was significantly reduced. Transwell migration and scratch experiment demonstrated decreased migration. Meanwhile, downregulation of MIS18BP1 resulted in an increase in cell apoptosis. In addition, P53, BAX and Cleaved Casepase-3 were increased, whereas BCL2 protein was decreased in the MIS18BP1-downregulated T24. After treatment with Pifithrin-α, the phenotype of cell proliferation inhibition was restored. MIS18BP1 overexpression may be regulated to poor prognosis in BCa patients. MIS18BP1 may associated with cell apoptosis and proliferation in BC cells. This process may be mediated by P53 signal pathway.

摘要

MIS18结合蛋白1(MIS18BP1)是MIS18复合体的一个亚基,特异性地聚集在末期-G1期着丝粒处,并调节癌细胞的凋亡、增殖和迁移。此前,关于MIS18BP1如何调节膀胱癌(BCa)细胞发育的机制尚不清楚。我们通过癌症基因组图谱(TCGA)、基因表达综合数据库(GEO)和通用蛋白质数据库分析了MIS18BP1在BCa中的差异表达。使用qRT-PCR检测MIS18BP1 mRNA的表达。通过蛋白质免疫印迹法和免疫组织化学(IHC)染色检测MIS18BP1蛋白的表达。用LV-MIS18BP1-RNAi载体转染T24细胞以降低MIS18BP1的表达。我们进行了一系列实验来检测T24细胞的存活、增殖和迁移情况。通过流式细胞术分析细胞凋亡。通过蛋白质免疫印迹法检测P53、BAX和裂解的半胱天冬酶-3的表达。在用P53抑制剂处理前后,分析细胞的P53凋亡相关蛋白、增殖和迁移情况。与对照组相比,BCa组织中MIS18BP1的表达更高。其表达与临床分期、浸润深度和淋巴结转移有关。我们发现与MIS18BP1密切相关的基因在生物学过程中主要与细胞周期、染色体分离和DNA修复相关。转染后,我们发现T24细胞的增殖能力显著降低。Transwell迁移实验和划痕实验表明细胞迁移减少。同时,MIS18BP1的下调导致细胞凋亡增加。此外,在MIS18BP1下调的T24细胞中,P53、BAX和裂解的半胱天冬酶-3增加,而BCL2蛋白减少。用pifithrin-α处理后,细胞增殖抑制表型得以恢复。MIS18BP1的过表达可能与BCa患者的不良预后相关。MIS18BP1可能与BC细胞的凋亡和增殖有关。这一过程可能由P53信号通路介导。

相似文献

1
MIS18BP1 promotes bladder cancer cell proliferation and growth via inactivating P53 signaling pathway.MIS18BP1通过使P53信号通路失活来促进膀胱癌细胞的增殖和生长。
Med Oncol. 2025 Apr 9;42(5):156. doi: 10.1007/s12032-025-02704-6.
2
Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.CPT2的下调通过p53通路促进结直肠癌的增殖并抑制其凋亡。
Cell Signal. 2022 Apr;92:110267. doi: 10.1016/j.cellsig.2022.110267. Epub 2022 Jan 30.
3
Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.核转运蛋白α2亚基(KPNA2)的过表达预示不良预后并通过P53途径促进膀胱癌致瘤性。
Med Sci Monit. 2020 Mar 9;26:e921087. doi: 10.12659/MSM.921087.
4
High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.TMEM40 的高表达与膀胱癌的恶性行为和肿瘤发生有关。
J Transl Med. 2018 Jan 19;16(1):9. doi: 10.1186/s12967-017-1377-3.
5
Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.输入蛋白11的过表达通过细胞周期蛋白依赖性激酶抑制剂1A(CDKN1A)和血小板反应蛋白1(THBS1)的失调促进膀胱癌的迁移、侵袭和进展。
Urol Oncol. 2018 Jun;36(6):311.e1-311.e13. doi: 10.1016/j.urolonc.2018.03.001. Epub 2018 Mar 27.
6
TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.膀胱癌中 TPX2-p53-GLIPR1 调控回路在细胞增殖、侵袭和肿瘤生长中的作用。
J Cell Biochem. 2018 Feb;119(2):1791-1803. doi: 10.1002/jcb.26340. Epub 2017 Sep 11.
7
Sakuranin represses the malignant biological behaviors of human bladder cancer cells by triggering autophagy via activating the p53/mTOR pathway.樱花素通过激活 p53/mTOR 通路引发自噬来抑制人膀胱癌细胞的恶性生物学行为。
BMC Urol. 2023 Oct 24;23(1):170. doi: 10.1186/s12894-023-01334-2.
8
Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.saRNA介导的靶向p53激活可抑制人膀胱癌细胞的生长和转移。
J Exp Clin Cancer Res. 2016 Mar 25;35:53. doi: 10.1186/s13046-016-0329-8.
9
UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.UPK1B 通过调控 Wnt/β-catenin 通路促进膀胱癌的侵袭转移。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5471-5480. doi: 10.26355/eurrev_201809_15807.
10
Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.抑癌基因 1 高甲基化(HIC1)通过靶向 yes 相关蛋白(YAP)通路抑制膀胱癌的进展。
J Cell Biochem. 2019 Apr;120(4):6471-6481. doi: 10.1002/jcb.27938. Epub 2018 Nov 11.

引用本文的文献

1
The Multifaceted Role of p53 in Cancer Molecular Biology: Insights for Precision Diagnosis and Therapeutic Breakthroughs.p53在癌症分子生物学中的多面角色:精准诊断与治疗突破的见解
Biomolecules. 2025 Jul 27;15(8):1088. doi: 10.3390/biom15081088.
2
RNA-binding protein AUF1 suppresses cellular senescence and glycolysis by targeting and mRNAs.RNA结合蛋白AUF1通过靶向 和 mRNA来抑制细胞衰老和糖酵解。
Aging (Albany NY). 2025 Jul 24;17(7):1746-1761. doi: 10.18632/aging.206286.

本文引用的文献

1
Mortality Study of Patients with Omicron Infection Before and After the Implementation of the New Crown Standard.奥密克戎感染患者实施新冠标准前后的死亡率研究。
Altern Ther Health Med. 2024 Oct;30(10):238-243.
2
Bladder cancer.膀胱癌。
Nat Rev Dis Primers. 2023 Oct 26;9(1):58. doi: 10.1038/s41572-023-00468-9.
3
Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?靶向突变型 p53 治疗癌症:我们做到了吗?
Curr Mol Pharmacol. 2024;17(1):e140923221042. doi: 10.2174/1874467217666230914090621.
4
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.PI3K/AKT/mTOR 信号转导通路与癌症的靶向治疗。
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
5
Raptinal ameliorates 1,2-dimethylhydrazine-induced colon cancer through p53/Bcl2/Bax/caspase-3-mediated apoptotic events and . Raptinal 通过 p53/Bcl2/Bax/caspase-3 介导的凋亡事件改善 1,2-二甲基肼诱导的结肠癌 。
Indian J Pharmacol. 2023 Mar-Apr;55(2):97-107. doi: 10.4103/ijp.ijp_168_22.
6
The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options.WNT 通路突变在癌症发展中的作用及治疗选择概述。
Cells. 2023 Mar 24;12(7):990. doi: 10.3390/cells12070990.
7
Targeting p53 pathways: mechanisms, structures, and advances in therapy.靶向 p53 通路:机制、结构和治疗进展。
Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1.
8
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.肿瘤微环境中免疫细胞的双重作用:促肿瘤和抗肿瘤作用及其触发因素。
Cancers (Basel). 2022 Mar 25;14(7):1681. doi: 10.3390/cancers14071681.
9
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.中国和美国 2022 年癌症统计数据:概况、趋势和决定因素。
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
10
Attenuates Photoaging by Regulating MAPK, NRF2, and NFATc1 Signaling Pathways.通过调节丝裂原活化蛋白激酶(MAPK)、核因子E2相关因子2(NRF2)和活化T细胞核因子1(NFATc1)信号通路减轻光老化。
Antioxidants (Basel). 2021 Nov 25;10(12):1882. doi: 10.3390/antiox10121882.